GL検索 v0.1.0
画像は 91 ページを描画したものです
page 91

p.91 抽出テキスト

method for differentiating retrograde conduction over an accessory AV pathway from conduction over the AV node. Circulation 1996; 94: 1027-1035. PMID: 8790042 446. Castellanos A, Myerburg RJ. The wide electrophysiologic spectrum of tachycardias having R-P intervals longer than the P-R intervals. Pacing Clin Electrophysiol 1987; 10: 1382- 1384. PMID: 2446285 447. Kaneko Y, Naito S, Okishige K, et al. Atypical fast-slow atrioventricular nodal reentrant tachycardia incorporating a “superior” slow pathway: A distinct supraventricular tachyarrhythmia. Circulation 2016; 133: 114-123. PMID: 26541829 448. Wolff L, Parkinson J, White PD. Bundle-branch block with short P-R interval in healthy young people prone to paroxysmal tachycardia. 1930. Ann Noninvasive Electrocardiol 2006; 11: 340- 353. PMID: 17040283 449. Obeyesekere MN, Leong-Sit P, Massel D, et al. Risk of arrhythmia and sudden death in patients with asymptomatic preexcitation: A meta-analysis. Circulation 2012; 125: 2308- 2315. PMID: 22532593 450. Rosenbaum FF, Hecht HH, Wilson FN, et al. The potential variations of the thorax and the esophagus in anomalous atrioventricular excitation (Wolff-Parkinson-White syndrome). Am Heart J 1945; 29: 281-326. 451. Ueda H, Nameki C, Saruta H, et al. Further studies on the W.P.W. Syndrome (pre-excitation syndrome) with special reference to the intracardiac and esophageal lead. Jpn Circ J 1957; 21: 361- 375. 452. Arruda MS, McClelland JH, Wang X, et al. Development and validation of an ECG algorithm for identifying accessory pathway ablation site in Wolff-Parkinson-White syndrome. J Cardiovasc Electrophysiol 1998; 9: 2-12. PMID: 9475572 453. Wackel P, Irving C, Webber S, et al. Risk stratification in Wolff-Parkinson-White syndrome: The correlation between noninvasive and invasive testing in pediatric patients. Pacing Clin Electrophysiol 2012; 35: 1451-1457. PMID: 22978820 454. Tada H, Naito S, Nogami A, et al. Successful catheter ablation of an anteroseptal accessory pathway from the noncoronary sinus of Valsalva. J Cardiovasc Electrophysiol 2003; 14: 544- 546. PMID: 12776875 455. Milstein S, Dunnigan A, Tang C, et al. Right atrial appendage to right ventricle accessory atrioventricular connection: A case report. Pacing Clin Electrophysiol 1997; 20: 1877- 1880. PMID: 9249846 456. Goya M, Takahashi A, Nakagawa H, et al. A case of catheter ablation of accessory atrioventricular connection between the right atrial appendage and right ventricle guided by a threedimensional electroanatomic mapping system. J Cardiovasc Electrophysiol 1999; 10: 1112-1118. PMID: 10466493 457. McClelland JH, Wang X, Beckman KJ, et al. Radiofrequency catheter ablation of right atriofascicular (Mahaim) accessory pathways guided by accessory pathway activation potentials. Circulation 1994; 89: 2655-2666. PMID: 8205678 458. Iesaka Y, Takahashi A, Goya M, et al. Adenosine-sensitive atrial reentrant tachycardia originating from the atrioventricular nodal transitional area. J Cardiovasc Electrophysiol 1997; 8: 854- 864. PMID: 9261711 459. Viskin S, Fish R, Glick A, et al. The adenosine triphosphate test: A bedside diagnostic tool for identifying the mechanism of supraventricular tachycardia in patients with palpitations. J Am Coll Cardiol 2001; 38: 173-177. PMID: 11451269 460. Garratt CJ, Antoniou A, Griffith MJ, et al. Use of intravenous adenosine in sinus rhythm as a diagnostic test for latent preexcitation. Am J Cardiol 1990; 65: 868-873. PMID: 2321537 461. Yamabe H, Okumura K, Koyama J, et al. Demonstration of anatomic reentrant circuit in verapamil-sensitive atrial tachycardia originating from the atrioventricular annulus other than the vicinity of the atrioventricular node. Am J Cardiol 2014; 113: 1822-1828. PMID: 24837259 462. Goya M, Iesaka Y, Takahashi A, et al. Radiofrequency catheter ablation for sinoatrial node reentrant tachycardia: Electrophysiologic features of ablation sites. Jpn Circ J 1999; 63: 177- 183. PMID: 10201618 463. Ouyang F, Ma J, Ho SY, et al. Focal atrial tachycardia originating from the non-coronary aortic sinus: Electrophysiological characteristics and catheter ablation. J Am Coll Cardiol 2006; 48: 122-131. PMID: 16814658 464.Yamabe H, Okumura K, Morihisa K, et al. Demonstration of anatomical reentrant tachycardia circuit in verapamilsensitive atrial tachycardia originating from the vicinity of the atrioventricular node. Heart Rhythm 2012; 9: 1475- 1483. PMID: 22583842 465.Chen SA, Tai CT, Chiang CE, et al. Focal atrial tachycardia: Reanalysis of the clinical and electrophysiologic characteristics and prediction of successful radiofrequency ablation. J Cardiovasc Electrophysiol 1998; 9: 355-365. PMID: 9581952 466. Chen SA, Chiang CE, Yang CJ, et al. Sustained atrial tachycardia in adult patients. Electrophysiological characteristics, pharmacological response, possible mechanisms, and effects of radiofrequency ablation. Circulation 1994; 90: 1262- 1278. PMID: 8087935 467. Kistler PM, Roberts-Thomson KC, Haqqani HM, et al. P-wave morphology in focal atrial tachycardia: Development of an algorithm to predict the anatomic site of origin. J Am Coll Cardiol 2006; 48: 1010-1017. PMID: 16949495 468. Suenari K, Lin YJ, Chang SL, et al. Lead aVL P-wave polarity: Insight from mapping and ablation of atrial arrhythmia initiated from superior vena cava. Pacing Clin Electrophysiol 2010; 33: e100-e101. PMID: 20345627 469. Tang CW, Scheinman MM, Van Hare GF, et al. Use of P wave configuration during atrial tachycardia to predict site of origin. J Am Coll Cardiol 1995; 26: 1315-1324. PMID: 7594049 470. Katritsis DG, Josephson ME. Differential diagnosis of regular, narrow-QRS tachycardias. Heart Rhythm 2015; 12: 1667-1676. PMID: 25828600 471. Gomes JA, Hariman RJ, Kang PS, et al. Sustained symptomatic sinus node reentrant tachycardia: Incidence, clinical significance, electrophysiologic observations and the effects of antiarrhythmic agents. J Am Coll Cardiol 1985; 5: 45-57. PMID: 3964808 472. Lee V, Hemingway H, Harb R, et al. The prognostic significance of premature ventricular complexes in adults without clinically apparent heart disease: a meta-analysis and systematic review. Heart 2012; 98: 1290-1298. PMID: 22781425 473. von Rotz M, Aeschbacher S, Bossard M, et al. Risk factors for premature ventricular contractions in young and healthy adults. Heart 2017; 103: 702-707. PMID: 27798051 474. Lee AKY, Andrade J, Hawkins NM, et al. Outcomes of untreated frequent premature ventricular complexes with normal left ventricular function. Heart 2019; 105: 1408- 1413. PMID: 31142596 475. Dukes JW, Dewland TA, Vittinghoff E, et al. Ventricular ectopy as a predictor of heart failure and death. J Am Coll Cardiol 2015; 66: 101-109. PMID: 26160626 476. Haïssaguerre M, Shoda M, Jaïs P, et al. Mapping and ablation of idiopathic ventricular fibrillation. Circulation 2002; 106: 962- 967. PMID: 12186801 477.Komatsu Y, Hocini M, Nogami A, et al. Catheter ablation of refractory ventricular fibrillation storm after myocardial infarction. Circulation 2019; 139: 2315-2325. PMID: 30929474 478. Cheema AN, Sheu K, Parker M, et al. Nonsustained ventricular tachycardia in the setting of acute myocardial infarction: Tachycardia characteristics and their prognostic implications. Circulation 1998; 98: 2030-2036. PMID: 9808601 479. Bigger JT Jr, Fleiss JL, Rolnitzky LM. Prevalence, characteristics and significance of ventricular tachycardia detected by 24hour continuous electrocardiographic recordings in the late hospital phase of acute myocardial infarction. Am J Cardiol 1986; 58: 1151-1160. PMID: 3788801 480. Maggioni AP, Zuanetti G, Franzosi MG, et al. Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era. GISSI- 2 results. Circulation 1993; 87: 312-322. PMID: 8093865 481. Kadish A, Dyer A, Daubert JP, et al. Defibrillators in Non- Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004; 350: 2151-2158. PMID: 15152060 482. Goldman S, Johnson G, Cohn JN, et al. Vasodilator-Heart Failure Trials. Mechanism of death in heart failure. The V-HeFT VA Cooperative Studies Group. Circulation 1993; 87 Suppl: VI24- VI31. PMID: 8500236 483. Singh SN, Fletcher RD, Fisher SG, et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. N Engl J Med 1995; 333: 77-82. PMID: 7539890 484. Doval HC, Nul DR, Grancelli HO, et al. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA). Randomised trial of low-dose amiodarone in severe congestive heart failure. Lancet 1994; 344: 493-498. PMID: 7914611 485. Teerlink JR, Jalaluddin M, Anderson S, et al. PROMISE